Figure 2.
Prophylactic use of antibiotics rather than anti-infective use before immunotherapy can provide survival benefits for patients with gastric cancer.

Kaplan–Meier analysis of overall survival and progression-free survival for patients who had been treated with antibiotics or without antibiotics (Prophylactic vs Infection: A and D; Prophylactic vs None: B and E; None vs Infection: C and F) within 1 month prior to start of immunotherapy in all patients.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close